不同阴道给药黄体支持方案对激素替代治疗周期冻融胚胎移植患者妊娠结局的影响
2020-04-03翟国敏高宇琳黄健初
翟国敏 高宇琳 黄健初


[摘要]目的 观察不同阴道给药黄体支持方案下,激素替代治疗周期冻融胚胎移植(FET)患者妊娠结局的变化情况。方法 选取东莞市妇幼保健院2013年2月~2018年7月接受的535个周期的激素替代治疗FET的临床资料进行回顾性分析,按照不同阴道给药方案分为A和B组。A组263个周期,均采用黄体酮阴道缓释凝胶(经阴道)配合地屈孕酮片(口服)方案;B组272个周期,采用黄体酮软胶囊(口服)配合地屈孕酮片(口服)方案。比较两组临床结局和不良反应发生情况。结果 A组胚胎着床率高于B组(P<0.05),早期流产率低于B组(P<0.05);A组不良反应总发生率低于B组,差异有统计学意义(P<0.05)。结论 将激素替代治疗周期FET两种阴道给药黄体支持方案比较,采用黄体酮阴道缓释凝胶(经阴道)配合地屈孕酮片(口服)方案患者胚胎种植率更高,早期流产率更低,且不良反应发生率更低。
[关键词]激素替代;周期冻融胚胎移植;生化妊娠;黄体支持
[中图分类号] R714.8 [文献标识码] A [文章编号] 1674-4721(2020)2(b)-0112-03
[Abstract] Objective To observe the changes of pregnancy outcome in patients with hormone replacement therapy and frozen-thawed embryo transfer (FET) under different vaginal administration Luteal support scheme. Methods The clinical data of a total of 535 cycles of hormone replacement therapy and cycle FET in the reproductive center of Dongguan Maternal and Child Health Hospital from February 2013 to July 2018 was selected for retrospective analysis. The patients were divided into group A and group B according to different vaginal administration schemes. Group A, a total of 263 cycles, patients were treated with Progesterone Vaginal Sustained Release Gel (transvaginal) with Dydrogesterone Tablets (oral). Group B, a total of 272 cycles, patients were treated with Progesterone Soft Capsules (oral) and Dydrogesterone Tablets (oral). The clinical outcomes and adverse reactions of the two groups were compared. Results The rate of embryos implantation in the group A was higher than that in the group B (P<0.05), and the rate of early abortion in the group A was lower than that in the group B (P<0.05). The total incidence of adverse reactions in the group A was lower than that in the group B, the differences were statistically significant (P<0.05). Conclusion Progesterone Vaginal Sustained Release Gel (transvaginal) with Dydrogesterone Tablets (oral) can significantly improve the rates of embryo implantation, decrease the rates of early abortion and adverse reaction.
[Key words] Hormone replacement therapy; Cycle frozen-thawed embryo transfer; Biochemical pregnancy; Luteal support
冻融胚胎移植技术(frozen embryo transfer,FET)[1-2]满足了大量临床患者繁衍后代的愿望,基本操作步骤是通过激素模拟正常月经周期,等到子宫内膜达到胚胎着床要求后,将体外FET植入内膜[3]。该方案存在因人工模拟周期而缺乏黄体激素支持缺陷,临床还补充药物以提供黄体支持[4-5],以此来改善患者妊娠结局。黄体支持方案按照不同的药物和给药途径分为多种类型,其中通过注射黄体酮方式在临床广泛使用,但其存在神经损伤可能性和注射风险。近年来,有研究[6-7]采用陰道给药和口服给药方式,避免了注射带来的风险,但其临床有效性和安全性尚待考察。本研究比较分析不同阴道给药黄体支持方案激素替代治疗周期FET患者的临床效果,以期指导临床,现报道如下。
1资料与方法
1.1一般资料
选取东莞市妇幼保健院2013年2月~2018年7月接受535个周期的激素替代治疗FET的临床资料进行回顾性分析。……
